Research
Energy balance
Both GLP-1RAs and combination therapy resulted in significant weight loss, with GLP-1RAs showing a mean weight loss of −5.2 kg at 12 months.
Practitioners can expect GLP-1RAs to aid in weight management for liver transplant recipients with diabetes.
StrongSupportsmedium confidence
These remained significant in the GLP‐1RA (−5.2 kg, 95% CI [−8.7, −1.7], p = 0.0039) and combination therapy groups.
Why this rating
The study is based on a retrospective analysis of prospectively collected data.
Source
<scp>Glucagon‐like peptide</scp> ‐1 receptor agonists and <scp>sodium‐glucose cotransporter</scp> ‐2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients
Katina Zheng et al. · Diabetes Obesity and Metabolism · 2024
cohort · n=362Cited 13×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →